학술논문
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
Document Type
Article
Author
Bhan, Amit; Campbell, Wayne; Chopra, Teena; Deck, Kenneth; Golan, Yoav; Gordon, Ian; Kamepalli, Ravi; Khanna, Sahil; Lee, Christine; Lucasti, Christopher; Maliakkal, Benedict; Minang, Irene; Mullane, Kathleen; Nathan, Richard; Oughton, Matthew; Pesant, Yves; Phillips, John; Pullman, John; Riska, Paul; Schrock, Christian; Siegel, Jonathan; Steinberg, Alon; Talan, David; Tamang, Stephen; Tan, Michael; Weiss, Karl; Wang, Chia; Yacyshyn, Bruce; Young, Jo-Anne; Zenilman, Jonathan; Vickers, Richard J; Tillotson, Glenn S; Hazan, Sabine; Tejura, Bina; Roblin, David; Gerding, Dale N; Wilcox, Mark H
Source
In The Lancet Infectious Diseases July 2017 17(7):735-744
Subject
Language
ISSN
1473-3099